PSA's Psychedelic State(s) of The Union: March 31st, 2026

By Jim Tate

From our friends at The Chronicles of Kykeon

In November 2000, federal agents surrounded a decommissioned Minuteman missile silo near Wamego, Kansas, and arrested Leonard Pickard. The DEA alleged he was the architect of the largest LSD manufacturing operation in American history. The bust made headlines. The conviction, two life sentences handed down in 2003, made history. But the story that the psychedelic community is still picking at, over 20 years later, is a quieter and uglier one. Who talked, and what did they say?

The primary informant in the Pickard case was Gordon Todd Skinner, a figure so strange and corrosive he almost defies description. Skinner was the man who owned the silo, who befriended Pickard, who invited him in, and who was simultaneously feeding information to the DEA. He later pled guilty in an unrelated case involving kidnapping and torture. The government’s star witness, in short, was a man who would go on to commit atrocities. But Skinner was not the only name attached to this case that generated controversy in psychedelic circles. The other was John Halpern, MD.

Halpern, at the time of Pickard’s arrest, was a psychiatrist at McLean Hospital affiliated with Harvard Medical School. He was one of the most respected researchers working in legitimate psychedelic science. He had done serious work on peyote use among the Native American Church. He was a credible, careful scientist operating in a field that desperately needed both. He was also, by multiple accounts, a personal acquaintance of Leonard Pickard.

The two men moved in overlapping worlds and according to the documented record, in overlapping finances. Between 1996 and 1999, Halpern accepted at least $319,000 in cash from Pickard. The exact purpose of those payments was never definitively established. Rumors persist that the money represented laundered drug proceeds. What is not in dispute is the amount, the cash nature of the transfers, or the timing. The cash payments were years before the arrest, while Pickard was allegedly running the largest LSD operation in American history. Hold that fact in mind because what happened next is where the story turns.

Within a month of Pickard’s arrest in November 2000 Halpern had signed on as a cooperating witness for the DEA. He went on to sign nine such reports through May 2002. He was also required, as part of that cooperation, to surreptitiously record phone conversations with associates who were suspected of involvement in the missile silo case. The man who had received nearly a third of a million dollars in cash from Leonard Pickard was now, by documented record, feeding information about Leonard Pickard’s world back to federal investigators.

The public reckoning came more than five years later. On January 13, 2006, at a LSD Symposium in Switzerland attended by much of the serious psychedelic research community something happened during Halpern’s presentation. An attendee interrupted Halpern’s talk and proceeded to read from a document detailing Halpern’s DEA cooperation. He read it from in front of the room and asked Halpern directly whether he had worked as a DEA agent. Halpern’s response did not satisfy the crowd. The moment was captured on video and is available on YouTube at https://tinyurl.com/2cne8fn2. The psychedelic community had a name for it almost immediately: “Halperngate.”

Inside that community, the reaction was swift and severe. Trust is the bedrock currency in a subculture that has spent decades operating on the margins of law, and the specifics made it worse. There were those nine reports, the recordings, and the timeline. Two days before Pickard and Apperson were found guilty in May 2003, Halpern had submitted a grant application to the National Institute on Drug Abuse to study MDMA-assisted psychotherapy. That grant was approved in September 2004, roughly ten months after sentencing. Whether there was any connection between the cooperation and the funding was never formally established, but the proximity was noted throughout the psychedelic community.

There’s a familiar tragedy in this dynamic. The people doing legitimate psychedelic research have always depended, at least partly, on the goodwill and trust of the underground. It was the outlaw chemists, guides, and practitioners who kept knowledge alive when it was illegal to study it. When that trust broke, it didn’t just damage relationships, it sent a chill through the entire ecosystem.

Rick Doblin, the founder of MAPS, tried to thread the needle publicly. MAPS had funded some of Halpern’s above ground research and Doblin said he had been aware of the DEA work. He told the Basel audience that he had spoken to Pickard by phone in prison and that Pickard himself had said he understood what MAPS was trying to do with Halpern and was supportive of the work. It was an unusual defense, and a revealing one as the man serving two life sentences was being cited to excuse the cooperation that helped put him there. Some in the community accepted it but many did not.

What makes the Halpern situation complicated is that the $319,000 cuts both ways. On one reading, a man who had taken that much cash from a suspected drug manufacturer had enormous legal exposure once the DEA came knocking. Federal investigators don’t always give you a choice about whether to cooperate. They come at you with documents and records of financial transfers. With the weight of prosecution hanging in the air. cooperation may not have felt optional. On another reading, a man who had taken that much cash from a suspected drug manufacturer and then helped build the case against him was doing something more calculated than survival. What Halpern knew, what he said, what he was asked, and what he was promised remain unanswered in the public record. Conveniently, perhaps, for everyone involved.

Leonard Pickard has maintained that the government’s case against him was substantially built on the work of compromised and self-interested informants. His novel, The Rose of Paracelsus, published while still incarcerated, is partly a meditation on betrayal and the peculiar ethics of the psychedelic underground. In 2020, he was granted compassionate release with the court citing his advanced age and medical condition in the context of the COVID-19 pandemic. He walked out of federal prison after nearly twenty years.

The informant question doesn’t go away because it points at something permanent and unresolved in the psychedelic world: the cost of operating, even legitimately, in the shadow of prohibition. Halpern went on to continue his research career. Pickard went to prison for life, then got out. Skinner, the man who built the trap, remains the most clearly villainous figure, yet he was also the most structurally predictable one. The government found him, used him, and discarded him.

The harder question is what it means when someone from inside the research community with standing and credentials, who had accepted $319,000 in cash from the man who would become the defendant, ends up on the same side as the DEA. Is it betrayal? Self-preservation? An arrangement that was always more transactional than it appeared? The purpose of the $319,000 was never formally adjudicated. The money laundering inference appears in community accounts, but Halpern was never charged with money laundering.

Is this tale a parable of humanity itself? Are we neither sinners nor saints but a mixture of the two? Can our entire lives be judged by the worst decisions we make on a dark day? And what about forgiveness and second chances? If our actions harm others, what are the steps to make amends to those that we have wronged? That first step might be to admit that we regret our actions. Granting second chances is a sign of openness and moving forward but maybe the transgressor needs to first take the step to admit that their actions caused harm. Bob Dylan sang “to live outside the law you must be honest”. In this case we can see that all hell can break lose when that moral guardrail is violated.

Feat. Stephanie Karzon Abrams - Founder of Beyond Consulting

From Psychedelic State(s) of America’s Monday News Roundup

Powered by Psychedelics Today

Stephanie Karzon Abrams joined the PSA Monday News Roundup on March 24th, 2026 to detail how Beyond Consulting's new women's health-focused psychedelic care protocol - GALILEA - is designed to rapidly integrate next-gen psychedelic treatment protocols and practices into the lagging western healthcare system of today.

Be sure to tune in LIVE to PSA’s News Roundup Series!

Mondays at 3:30 PM EST / 12:30 PM PST

Fridays at 2:00 PM EST / 11:00 AM PST

Learn more about PSA’s Media Partnership Program Here

Until next time,

The Psychedelic State(s) of America Team